Daylight photodynamic therapy for actinic keratoses: a randomized double‐blinded nonsponsored prospective study comparing 5‐aminolaevulinic acid nanoemulsion ( <scp>BF</scp> ‐200) with methyl‐5‐aminolaevulinateNoora Neittaanmäki, Erna Snellman, Toni Karppinen et al.|British Journal of Dermatology|2014Cited by 76
Photodynamic Therapy for Actinic Keratoses: A Randomized Prospective Non-sponsored Cost-effectiveness Study of Daylight-mediated Treatment Compared with Light-emitting Diode TreatmentNoora Neittaanmäki, Pekka Rissanen, M Grönroos et al.|Acta Dermato Venereologica|2015Cited by 18
Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trialNoora Neittaanmäki, Erna Snellman, M Grönroos et al.|British Journal of Dermatology|2015Cited by 18
Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic KeratosesNoora Neittaanmäki, M Grönroos, Toni Karppinen et al.|Acta Dermato Venereologica|2016Cited by 9
<i>TERT</i> promoter mutations in actinic keratosis before and after treatmentNalini Srinivas, Rajiv Kumar, Kari Hemminki et al.|International Journal of Cancer|2020Cited by 7